Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer
Lucicer
Lucicer is a second-generation selective inhibitor of anaplastic lymphoma kinase taken orally (ALK). By preventing ALK autophosphorylation, Lucicer disrupts downstream signaling cascades and slows the development of ALK-dependent cancer cells.
Trade name
Lucicer
Manufacturer
Lucius
Main ingreadient
Ceritinib
Specification
150mg*50 tablets
Logistics
Please discuss the logistics method with the customer service executive on customer service whatsapp/wechat/zalo/viber account
Reminder
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.
Lucicer is a kinase inhibitor, which is a type of medication. It works by preventing cancer cells from developing by suppressing the action of an abnormal protein. Lucicer is a drug used to treat non-small cell lung cancer (NSCLC) caused by a mutation in the ALK gene (anaplastic lymphoma kinase). It's for people with advanced non-small-cell lung cancer (NSCLC) who have an FDA-approved test that shows their tumors are positive for anaplastic lymphoma kinase (ALK).